source
- Eli Lilly lifts guidance by $10 billion as GLP‑1 sales outpace expectationsEli Lilly said its latest financial guidance is $10 billion higher than previously forecast, driven by strong sales of its GLP‑1 medicines. The company’s commercial performance has repeatedly excee…
- Bristol Myers Squibb emphasizes pipeline strength and later-stage partnership focus amid patent cliff concernsBristol Myers Squibb used its latest earnings call to outline how it plans to address an upcoming patent cliff that threatens revenue from several key products. Executives said the company is rely…